Articles | Volume 6, issue 8
https://doi.org/10.5194/jbji-6-337-2021
https://doi.org/10.5194/jbji-6-337-2021
Original full-length article
 | 
07 Sep 2021
Original full-length article |  | 07 Sep 2021

Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infections

Truong-Thanh Pham, Eugénie Mabrut, Philippe Cochard, Paul Chardon, Hassan Serrier, Florent Valour, Laure Huot, Michel Tod, Gilles Leboucher, Christian Chidiac, and Tristan Ferry

Related authors

Optimized decision algorithm for the microbiological diagnosis of osteoarticular infections in adults using synovial fluid samples: a prospective study in two French hospitals including 423 samples of synovial fluid
Céline Dupieux, Ghislaine Descours, Paul Verhoeven, Florence Grattard, Yvonne Benito, François Vandenesch, Céline Cazorla, Tristan Ferry, Sébastien Lustig, Bertrand Boyer, Sandrine Boisset, Anne Carricajo, Frédéric Laurent, and PIRLA investigator group
J. Bone Joint Infect., 9, 37–48, https://doi.org/10.5194/jbji-9-37-2024,https://doi.org/10.5194/jbji-9-37-2024, 2024
Short summary
Lysins – a new armamentarium for the treatment of bone and joint infections?
Parham Sendi and Tristan Ferry
J. Bone Joint Infect., 7, 187–189, https://doi.org/10.5194/jbji-7-187-2022,https://doi.org/10.5194/jbji-7-187-2022, 2022
Osteocutaneous-flap-related osteomyelitis following mandibular reconstruction: a cohort study of an emerging and complex bone infection
Clément Javaux, Clémentine Daveau, Clotilde Bettinger, Mathieu Daurade, Céline Dupieux-Chabert, Fabien Craighero, Carine Fuchsmann, Philippe Céruse, Arnaud Gleizal, Nicolas Sigaux, Tristan Ferry, Florent Valour, and the Lyon BJI study group
J. Bone Joint Infect., 7, 127–136, https://doi.org/10.5194/jbji-7-127-2022,https://doi.org/10.5194/jbji-7-127-2022, 2022
Short summary

Related subject area

Subject: Other | Topic: All topics
Orthopedic infectious diseases: a survey on the composition and perceived value of an emerging subspecialty clinical service
Nicolás Cortés-Penfield, Don Bambino Geno Tai, and Angela Hewlett
J. Bone Joint Infect., 9, 161–165, https://doi.org/10.5194/jbji-9-161-2024,https://doi.org/10.5194/jbji-9-161-2024, 2024
Short summary
Development of an evidence-based diagnostic algorithm for infection in patients with transcutaneous osseointegration following amputation
Shafaf Hasin Alam, Jason S. Hoellwarth, Kevin Tetsworth, Atiya Oomatia, Tristen N. Taylor, and Munjed Al Muderis
J. Bone Joint Infect., 9, 49–57, https://doi.org/10.5194/jbji-9-49-2024,https://doi.org/10.5194/jbji-9-49-2024, 2024
Short summary
Clinical–epidemiological profile of confirmed cases of osteoarticular tuberculosis
Caroline Thomaz Panico, Priscila Rosalba Domingos de Oliveira, Vladimir Cordeiro de Carvalho, Angélica Makio dos Anjos, Vanessa Ferreira Amorim de Melo, and Ana Lucia Lei Munhoz Lima
J. Bone Joint Infect., 8, 11–17, https://doi.org/10.5194/jbji-8-11-2023,https://doi.org/10.5194/jbji-8-11-2023, 2023
Short summary
Mycetoma caused by Madurella mycetomatis in immunocompromised patients – a case report and systematic literature review
Lotje A. Hoogervorst, Lindsey S. op de Coul, Arghya Ray, Pieter Bas de Witte, and Mark G. J. de Boer
J. Bone Joint Infect., 7, 241–248, https://doi.org/10.5194/jbji-7-241-2022,https://doi.org/10.5194/jbji-7-241-2022, 2022
Short summary
Local antibiotic treatment with calcium sulfate as carrier material improves the outcome of debridement, antibiotics, and implant retention procedures for periprosthetic joint infections after hip arthroplasty – a retrospective study
Katharina Reinisch, Michel Schläppi, Christoph Meier, and Peter Wahl
J. Bone Joint Infect., 7, 11–21, https://doi.org/10.5194/jbji-7-11-2022,https://doi.org/10.5194/jbji-7-11-2022, 2022
Short summary

Cited articles

Association for Accessible Medicines: 2020 Generic Drug & Biosimilars Access & Savings in the U.S. Report, available at: https://accessiblemeds.org/2020-Access-Savings-Report, last access: 14 June 2021. 
Berbari, E. F., Kanj, S. S., Kowalski, T. J., Darouiche, R. O., Widmer, A. F., Schmitt, S. K., Hendershot, E. F., Holtom, P. D., Huddleston 3rd, P. M., Petermann, G. W., Osmon, D. R., and Infectious Diseases Society of, A.: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults, Clin. Infect. Dis., 61, e26–46, https://doi.org/10.1093/cid/civ482, 2015. 
Carvalhaes, C. G., Sader, H. S., Flamm, R. K., and Mendes, R. E.: Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014–17), J. Antimicrob. Chemother., 74, 1928–1933, https://doi.org/10.1093/jac/dkz120, 2019. 
da Silva, R. B. and Salles, M. J.: Outcomes and Risk Factors in Prosthetic Joint Infections by multidrug-resistant Gram-negative Bacteria: A Retrospective Cohort Study, Antibiotics (Basel), 23, 340, https://doi.org/10.3390/antibiotics10030340, 2021. 
Decollogny, A., Eggli, Y., Halfon, P., and Lufkin, T. M.: Determinants of generic drug substitution in Switzerland, BMC Health Serv. Res., 11, 17, https://doi.org/10.1186/1472-6963-11-17, 2011. 
Download
Short summary
Costs related to off-label expensive antibiotics used to treat bone and joint infections (BJIs) in a referral centre in France were analysed in this cohort study. Despite the large increase in the number of patients treated with these antibiotics, the overall costs remained stable (approximately EUR 1 million) and were helped by the appearance of generic molecules at lower prices. Production of generic antibiotics at low cost is essential to limit the financial burden of the management of BJIs.